Shares of agilon health, inc. (NYSE:AGL – Get Free Report) have earned a consensus recommendation of “Hold” from the seventeen analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $9.46.
AGL has been the subject of several research analyst reports. Royal Bank of Canada dropped their price target on agilon health from $11.00 to $8.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $6.50 target price (down previously from $25.00) on shares of agilon health in a research note on Monday, February 26th. Benchmark lowered their target price on agilon health from $13.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Truist Financial lowered their target price on agilon health from $10.00 to $7.50 and set a “hold” rating for the company in a research note on Thursday, February 29th. Finally, Barclays assumed coverage on agilon health in a research note on Wednesday, March 6th. They issued an “underweight” rating and a $5.00 target price for the company.
Get Our Latest Analysis on agilon health
Institutional Inflows and Outflows
agilon health Stock Performance
agilon health stock opened at $5.13 on Friday. The firm has a market capitalization of $2.11 billion, a P/E ratio of -7.89 and a beta of 0.49. The stock has a fifty day moving average price of $5.60 and a 200 day moving average price of $9.60. agilon health has a 52 week low of $4.41 and a 52 week high of $26.75. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.05.
agilon health (NYSE:AGL – Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.13). The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The business’s revenue for the quarter was up 71.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.14) earnings per share. Equities research analysts anticipate that agilon health will post -0.35 earnings per share for the current year.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
- Five stocks we like better than agilon health
- Where Do I Find 52-Week Highs and Lows?
- Hasbro’s Management Made All the Right Calls This Quarter
- The How and Why of Investing in Gold Stocks
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Conference Calls and Individual Investors
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.